SCOPUS 정보 검색 플랫폼

Volumn 46, Issue 2, 2000, Pages 167-171

Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: A study of the EORTC early clinical studies group (ECSG)

(12) Pavlidis, Nicholas a Aamdal, Steinar b Awada, Ahmad c Calvert, Hilary d Fumoleau, Pierre e Sorio, Roberto f Punt, Cees g Verweij, Jaap h Van Oosterom, Allan i Morant, Rudolf j Wanders, Jantien k Hanauske, Axel R i

a UNIVERSITY OF IOANNINA (Greece)

b OSLO UNIVERSITY HOSPITAL (Norway)

c JULES BORDET INSTITUTE (Belgium)

d NEWCASTLE GENERAL HOSPITAL (United Kingdom)

e CENTRE RENÉ GAUDUCHEAU (France)

f CENTRO DI RIFERIMENTO ONCOLOGICO (Italy)

g RADBOUD UNIVERSITY MEDICAL CENTER (Netherlands)

h ERASMUS MC CANCER INSTITUTE (Netherlands)

i UNIVERSITY HOSPITALS LEUVEN (Belgium)

more..

Author keywords

Carzelesin; Lymphoma; Solid tumors; Toxicity

Indexed keywords

CARZELESIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; BONE MARROW DEPRESSION; BONE MARROW TOXICITY; BREAST CANCER; CLINICAL TRIAL; COLORECTAL CANCER; COVALENT BOND; FEMALE; FEVER; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEUTROPENIA; NONHODGKIN LYMPHOMA; OVARY CANCER; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STOMACH CANCER; THROMBOCYTOPENIA;

EID: 0033880045 PISSN: 03445704 EISSN: None Source Type: Journal
DOI: 10.1007/s002800000134 Document Type: Article

Times cited : (30)

References (13)

1
- 0033014899
- Phase I study of carzelesin (U-80,244) given (4-weekly) by intravenous bolus schedule
- (1999) Br J Cancer , vol.79 , pp. 1454
- Awada, A.¹ Punt, C.J.A.² Piccart, M.J.³ Van Tellingen, O.⁴ Van Manen, L.⁵ Groot, Y.⁶ Wanders, J.⁷ Verweij, J.⁸ Wagenet, D.J.T.H.⁹

2
- 0030763108
- Hematopoietic toxicity and cell cycle perturbations induced by new DNA minor groove-alkylating agents
- (1997) Int J Cancer , vol.72 , pp. 801
- Filippini, C.¹ Bisiach, M.² Tagliabue, G.³ D'Incalci, M.⁴ Ubezio, P.⁵

3
- 0028223967
- Phase I study of adozelesin administered by 24-hour continuous intravenous infusion
- (1994) J Natl Cancer Inst , vol.86 , pp. 368
- Fleming, G.F.¹ Ratain, M.J.² O'Brien, S.M.³ Schilsky, R.L.⁴ Hoffman, P.C.⁵ Richards, J.M.⁶ Vogelzang, N.J.⁷ Kasunic, D.A.⁸ Earhart, R.H.⁹

4
- 0028919512
- Therapeutic efficacy of the cyclopropylpyrroloindole, carzelesin, against xenografts derived from adult and childhood solid tumours
- (1995) Cancer Chemother Pharmacol , vol.36 , pp. 45
- Houghton, P.J.¹ Cheshire, P.J.² Hallman, J.D.³ Houghton, J.A.⁴

5
- 0021715394
- Reaction of the antitumor antibiotic CC-1065 with DNA: Structure of a DNA adduct with DNA sequence specificity
- (1984) Science , vol.226 , pp. 843
- Hurley, L.H.¹ Reynolds, V.L.² Swenson, D.H.³ Petzold, G.L.⁴ Scahill, T.A.⁵

6
- 0026350933
- DNA damage and differential cytotoxicity produced in human carcinoma cells by CC-1065 analogues U-73,975 and U-77,779
- (1991) Cancer Res , vol.51 , pp. 6586
- Lee, C.S.¹ Gibson, N.W.²

7
- 0025753312
- Adozelesin, a selected lead among cyclopropylpyrroloindole analogs of the DNA-binding antibiotic, CC-1065
- (1991) Invest New Drugs , vol.9 , pp. 137
- Li, L.H.¹ Kelly, R.C.² Warpehoski, M.A.³ McGovren, J.P.⁴ Gebhard, I.⁵ DeKoning, T.F.⁶

8
- 0026786973
- Cytotoxicity and antitumor activity of Carzelesin, a prodrug cyclopropylpyrroloindole analogue
- (1992) Cancer Res , vol.52 , pp. 4904
- Li, L.H.¹ DeKoning, T.F.² Kelly, R.C.³ Kruger, W.C.⁴ McGovren, J.P.⁵ Padbury, G.E.⁶ Petzold, G.L.⁷ Wallace, T.L.⁸ Ouding, R.J.⁹ Prairie, M.D.¹⁰ Gebhard, I.¹¹

9
- 0022358966
- Reaction of the antitumor antibiotic CC-1065 with DNA. Location of the site of the thermally induced strand breakage and analysis of DNA sequence specificity
- (1985) Biochemistry , vol.24 , pp. 6228
- Reynolds, V.L.¹ Molineux, I.J.² Kaplan, D.J.³ Swenson, D.H.⁴ Hurley, L.H.⁵

10
- 0028082283
- Phase I study of adozelesin (U-73,975) in patients with solid tumours
- (1994) Anti-cancer Drugs , vol.5 , pp. 10
- Shamdas, G.J.¹ Alberts, D.S.² Modiano, M.³ Wiggins, C.⁴ Power, J.⁵ Kasunic, D.A.⁶ Elfring, G.L.⁷ Earhart, R.H.⁸

11
- 15444356610
- A clinical pharmacokinetics study of carzelesin given by short-term intravenous infusion in a phase I study
- (1998) Cancer Chemother Pharmacol , vol.41 , pp. 377
- Van Tellingen, O.¹ Punt, C.J.A.² Awada, A.³ Wagener, D.J.T.⁴ Piccart, M.J.⁵ Groot, Y.⁶ Schaaf, L.J.⁷ Henrar, R.E.C.⁸ Nooijen, W.J.⁹ Beijnen, J.H.¹⁰

12
- 0024240366
- Sequence selectivity of DNA covalent modification
- (1988) Chem Res Toxicol , vol.1 , pp. 315
- Warpehoski, M.A.¹ Hurley, L.H.²

13
- 10244249179
- Phase I clinical and pharmacokinetic study of carzelesin (U-80244) given on a daily x5 schedule
- (1996) Clin Cancer Res , vol.2 , pp. 1717
- Wolff, I.¹ Bench, K.² Beijnen, J.C.³ Bruntsch, U.⁴ Cavalli, F.⁵ De Jong, J.⁶ Groot, Y.⁷ Van Tellingen, O.⁸ Wanders, J.⁹ Sessa, C.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.